Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis

NCT02344719 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Cirrhosis
Portal Hypertension

Interventions

DRUG: Taurin 6g per day per oral for 28 days
PROCEDURE: HVPG Measurement baseline
PROCEDURE: HVPG Measurement day 28
DRUG: Placebo 6g per day per oral for 28 days

Sponsor

Medical University of Vienna